成人神经内科诊所中的先天性肌无力综合征:漫长诊断与治疗之路
该研究回顾性分析了2000至2016年间在Mayo Clinic神经肌肉门诊成年后确诊的34例先天性肌无力综合征(CMS)患者,发现94%曾被误诊,从症状出现到确诊的中位延迟约26年,最常见的误诊为血清阴性重症肌无力和肌肉疾病,导致不必要的免疫治疗或胸腺切除。
要点
- 成人CMS患者中94%曾被误诊,中位诊断延迟为26年(范围4-56年)。
- 最常见的误诊为血清阴性重症肌无力(16例)和肌肉疾病(15例)。
- 15例接受免疫治疗或胸腺切除无获益,14/25例使用吡啶斯的明未改善或恶化。
核心结论
- 94%的成人CMS患者曾被误诊,从症状出现到确诊的中位延迟近3个十年。
- 血清阴性重症肌无力和肌肉疾病是最常见的两种误诊,导致治疗延迟和不必要的免疫治疗、胸腺切除或肌肉活检。
研究设计与样本
- 回顾性研究,搜索Mayo Clinic数据库,纳入2000至2016年间在神经肌肉门诊成年后确诊的CMS患者,共34例,回顾临床、实验室和电生理数据。
主要发现
- 34例CMS患者中30例有分子诊断(14例DOK7,6例RAPSN,2例LRP4,2例COLQ,2例慢通道综合征,1例原发性乙酰胆碱受体缺陷,1例AGRN,1例GFPT1,1例SCN4A)。
- 眼肌麻痹常较轻,见于13例;以肢体-肩带肌无力为主者19例;仅上睑下垂者2例。
- 发病年龄从出生至39岁(中位5岁),从发病到确诊的中位时间为26年(范围4-56年)。
- 13例有受累家庭成员;检查时存在疲劳性无力;23例中4例肌酸激酶升高(范围为正常上限的1.2-4.2倍);30例重复神经刺激显示递减。
- 32例曾被误诊为血清阴性重症肌无力(16例)、肌肉疾病(15例)、原因不明的无力(8例)和其他(4例);15例接受免疫治疗或胸腺切除无获益;25例接受吡啶斯的明治疗者中14例未改善或恶化。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the diagnostic challenges of congenital myasthenic syndromes (CMS) in adult neuromuscular practice. METHODS: We searched the Mayo Clinic database for patients with CMS diagnosed in adulthood in the neuromuscular clinic between 2000 and 2016. Clinical, laboratory, and electrodiagnostic data were reviewed. RESULTS: We identified 34 patients with CMS, 30 of whom had a molecular diagnosis (14 DOK7, 6 RAPSN, 2 LRP4, 2 COLQ, 2 slow-channel syndrome, 1 primary acetylcholine receptor deficiency, 1 AGRN, 1 GFPT1, and 1 SCN4A). Ophthalmoparesis was often mild and present in 13 patients. Predominant limb-girdle weakness occurred in 19 patients. Two patients had only ptosis. Age at onset ranged from birth to 39 years (median 5 years). The median time from onset to diagnosis was 26 years (range 4-56 years). Thirteen patients had affected family members. Fatigable weakness was present when examined. Creatine kinase was elevated in 4 of 23 patients (range 1.2-4.2 times the upper limit of normal). Repetitive nerve stimulation revealed a decrement in 30 patients. Thirty-two patients were previously misdiagnosed with seronegative myasthenia gravis (n = 16), muscle diseases (n = 15), weakness of undetermined cause (n = 8), and others (n = 4). Fifteen patients received immunotherapy or thymectomy without benefits. Fourteen of the 25 patients receiving pyridostigmine did not improve or worsen. CONCLUSION: Misdiagnosis occurred in 94% of the adult patients with CMS and causes a median diagnostic delay of nearly 3 decades from symptom onset. Seronegative myasthenia gravis and muscle diseases were the 2 most common misdiagnoses, which led to treatment delay and unnecessary exposure to immunotherapy, thymectomy, or muscle biopsy.
引用
- Kao JC, Milone M, Selcen D, et al. Congenital myasthenic syndromes in adult neurology clinic: A long road to diagnosis and therapy. Neurology. 2018. PMID: 30291185. doi:10.1212/WNL.0000000000006478
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。